Goodwill and Other Intangible Assets

3 Months Ended

Jan. 31, 2015

Goodwill And Intangible Assets Disclosure [Abstract]

4.	Goodwill and other intangible assets

Changes in the carrying amount of goodwill for the three months ended January 31, 2015 by operating segment are as follows:

	Adhesive Dispensing Systems			Advanced Technology Systems			Industrial Coating Systems		Total
Balance at October 31, 2014	$	397,046		$	631,433		$	24,058	$	1,052,537
Adjustment					371					371
Currency effect		(11,779	)		(1,084	)		—		(12,863	)
Balance at January 31, 2015	$	385,267		$	630,720		$	24,058	$	1,040,045

Accumulated impairment losses, which were recorded in 2009, were $232,789 at January 31, 2015 and October 31, 2014. Of these losses, $229,173 related to the Advanced Technology Systems segment, and $3,616 related to the Industrial Coating Systems segment.

Information regarding our intangible assets subject to amortization is as follows:

	January 31, 2015
	Carrying Amount		Accumulated Amortization		Net Book Value
Customer relationships	$	194,222	$	44,596	$	149,626
Patent/technology costs		91,351		27,821		63,530
Trade name		77,363		13,245		64,118
Non-compete agreements		8,005		7,525		480
Other		1,368		1,273		95
Total	$	372,309	$	94,460	$	277,849

	October 31, 2014
	Carrying Amount		Accumulated Amortization		Net Book Value
Customer relationships	$	200,028	$	41,910	$	158,118
Patent/technology costs		93,799		27,030		66,769
Trade name		77,846		12,173		65,673
Non-compete agreements		8,220		7,600		620
Other		1,369		1,239		130
Total	$	381,262	$	89,952	$	291,310

Amortization expense for the three months ended January 31, 2015 and 2014 was $6,891 and $6,330, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details